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Background: Idiopathic intracranial hypertension is a condition typically characterised by headache, normal level of
consciousness, papilloedema and raised cerebrospinal fluid pressure. Children often present with visual loss and
atypical features of raised pressure, posing a diagnostic and management challenge. A range of renal disorders can
predispose to developing this raised intracranial pressure syndrome. We present a case of severe visual failure in a
child with nephrotic syndrome, with no headache when elevated pressure was proven. In nephrotic syndrome,
visual failure related to elevated intracranial pressures without concurrent headache symptoms has not been
reported previously.
Case presentation: We discuss a 5-year-old Caucasian girl with steroid sensitive nephrotic syndrome who went on
to become a late non-responder and presented with intracranial hypertension. Following initial response to
steroids, she had a relapse of her nephrotic syndrome; her proteinuria did not resolve on steroid treatment,
requiring addition of cyclosporine therapy to manage her nephrotic syndrome. Three months following this, she
presented with visual failure in the right eye with bilateral central scotoma and papilloedema. At the time of
presentation of visual impairment, she was otherwise well, with no symptoms of a raised intracranial pressure
syndrome or associated systemic illness. Medical management was initiated following confirmation of a raised
intracranial pressure. Her intracranial pressure remained elevated requiring serial therapeutic lumbar punctures
before some improvement in visual acuity was observed. Later in the clinical course, she presented with worsening
of her visual impairment with further deterioration of the vision in the left eye, again associated with elevated
intracranial pressure. An urgent surgical cerebrospinal fluid diversion procedure was performed. At review, three
years after presentation our patient has severe visual impairment with no perception of light in her right eye and 6/
36 Snellen acuity in the left secondary to optic atrophy.
Conclusion: Our case demonstrates the occurrence of intracranial hypertension in nephrotic syndrome,
highlighting the atypical presentation of severe visual failure without concurrent headache at presentation. This
demonstrates the management complexities and the need for clear guidelines for ophthalmological surveillance to
aim to reduce permanent visual impairment.
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Nephrotic syndrome (NS) is characterised by the presence
of heavy proteinuria, hypoalbuminaemia and generalised
oedema [1]. During childhood NS is often ‘idiopathic’ and
on biopsy associated with minimal change nephropathy
on light microscopy [2].
The majority of children have steroid responsive - so
called steroid sensitive - NS and in the absence of any
complicating features are treated expectantly with high
dose daily steroid therapy. Typically a large number of
children with NS develop clinical relapse following
initial response to steroids, and are treated with further
steroid courses. Following initial presentation a small
proportion of children with relapsing NS go on to de-
velop steroid dependent disease. In these cases add-
itional immunosuppresants are often used to reduce
the relapsing clinical course and/or to reduce the dose
of steroids.
NS and its treatment are associated with significant
morbidity and the complications can be fatal. In NS,
renal failure, corticosteroids, cyclosporine therapy and
cerebral venous thrombosis all contribute to central
nervous system complications, which include intracra-
nial hypertension.
Idiopathic intracranial hypertension (IIH) comprises a
headache syndrome with an elevated intracranial pressure
(greater than 250 mmH2O), where the cerebrospinal fluid
(CSF) composition is normal, and no evidence of a struc-
tural cause is identified [3]. A recent study of normal CSF
pressure in children concluded that similar adult pressure
norms of less than 280 mmH2O are applicable to child-
hood cases [4].
In adults visual symptoms occur in virtually all patients
although these may be mild and not noted by the patients
[5]. However, loss of visual acuity, restriction in the visual
fields, increased blind spots and reduced colour vision
form the serious permanent complication of IIH [5]. In
children similar long-term visual morbidity has been
reported and appears to be more severe in patients that
present atypically without headaches [6]. A pressure re-
duction strategy is crucial to minimise the visual impair-
ment seen in this condition, alongside identifying and
eliminating associated factors [5]. Medical management,
serial lumbar puncture (LP) or surgical management are
treatment options in adults [5] and children [7] with IIH.
Here we report a patient with steroid dependent NS pre-
senting acutely with severe visual failure and papiloedema
without concurrent headaches, and found to have signifi-
cantly raised CSF pressure.
Case presentation
A 5-year-old girl presented with proteinuria, serum
albumin of 18 g/L, and oedema. She was normotensive
with no evidence of significant intravascular depletion.Her renal function was normal. She was commenced on
steroid therapy and achieved remission a few days follow-
ing commencement of steroids, thus confirming steroid
sensitive NS. Unfortunately, five months after her steroid
treatment was weaned she developed a clinical relapse of
her nephrotic syndrome. She recommenced treatment
with high dose steroid therapy. Again she responded
within one week of commencing steroid treatment. How-
ever, when the steroid-weaning regimen was started, she
suffered further proteinurea. Despite the return to high
dose steroids she failed to achieve remission after 4 weeks
of daily oral steroid treatment at 60 mg/m2, and 3 day
of IV methylprednisolone at 600 mg/m2. A percutaneous
renal biopsy was performed at this point and confirmed
minimal change disease. Following the renal biopsy she
was commenced on cyclosporine (5 mg/kg/day) therapy
and alternate day steroid therapy at 40 mg/m2 and went
on to achieve remission in one week. Her renal function
remained normal.
Ten months following initial presentation of NS, and
three months after commencing cyclosporine treatment,
the patient noted an enlarged blind spot in the vision in
the right eye. She had no other symptoms suggestive of
a raised pressure syndrome or associated systemic ill-
ness. At the time of this presentation she was in clinical
remission from her NS and was taking prednisolone
(1 mg/kg alternate days) and continued on cyclosporine
(5 mg/kg/day). Her visual acuity was reduced to finger
counting at less than one metre in her right eye with
additional total loss of colour vision. In the left eye the
visual acuity was 6/9 and colour vision was preserved.
Visual field assessment identified an enlarged blind spot
with absence of forward vision noted by the patient.
Examination revealed bilateral papilloedema.
Magnetic resonance imaging did not suggest a structural
cause for a potential raised pressure syndrome, prompting
a LP that confirmed a significantly elevated CSF pressure
(> 400 mm H2O). Her intracranial pressure was reduced
to 240 mm H2O post CSF drainage at LP and she was
then commenced on acetazolamide (30 mg/kg/day). Her
cyclosporine dose was reduced to account for the possible
contributing role of this drug to increased intracranial
pressure [8]. A computerised tomography venogram study
did not identify an acute thrombosis, although a parallel
sagittal sinus was noted. On review of her history, she had
an episode of severe headaches and vomiting lasting four
weeks, two months after her diagnosis of NS. She was
completing her weaning dose of steroids at this time and
requiring admission to hospital for 2 days. She was conser-
vatively managed. Taken together with the venographic
changes, it was clinically plausible that she might have had
a sinus venous thrombosis during that event. Her vision
was confirmed to be normal at that time, and she did not
have any further headaches, particularly throughout her
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found visual failure.
Unfortunately, her intracranial hypertension remained
refractory despite optimised pharmacological therapy
with acetazolamide (60 mg/kg/day). With additional and
numerous LPs, her vision improved and stabilised with
residual deficit. She remained asymptomatic without a
headache after the diagnosis of intracranial hypertension
was made.
One month following diagnosis of intracranial hyper-
tension our patient suffered a clinical relapse of her
nephrotic syndrome. At this time she was on a reduced
dose of 2.4 mg/kg/day of cyclosporine (trough level of
20 ng/L), which was therefore titrated up to a target
trough level of 100 ng/L. Her proteinuria resolved with
this management alone and an increase in the dose of
steroid therapy was not needed. One week following the
increased cyclosporine dose she presented with a further
deterioration of her vision with 6/18 vision in the left eye
and non-useful vision in the right eye. Acetazolamide dose
was increased to 90 mg/kg/d and therapeutic LPs were
reinstituted to bring pressures to between 200–250
mmH2O. There was an improvement in the visual acuity
in her left eye following CSF drainage. Due to the clinical
presentation and reported association of cyclosporine
therapy and IIH, her immunomodulation therapy was
converted to mycophenolate mofetil (1200 mg/m2/day).
As the improvement of her vision was not sustained and
her intracranial pressures remained elevated, she under-
went an urgent surgical cerebrospinal fluid diversion
procedure.
Over the next few months, her pressures stabilized
(acetazolamide 30 – 90 mg/kg/ day was continued and
furosemide 1 mg /kg/d was added for a period) in between
numerous episodes of raised pressure, presumed to be re-
lated to shunt failure. Our patient has undergone two
shunt revisions. Three years following initial presentation
of her intracranial hypertension she remains severely visu-
ally impaired with non-useful vision in her right eye, and
6/36 vision in the left. Her pharmacological treatment for
intracranial pressure is currently being withdrawn very
gradually. Her nephrotic syndrome remains in remission
on treatment with mycophenolate mofetil (600 mg/m2/
day) and alternate day prednisolone (20 mg).
Conclusions
In this report we have presented a case of a child with
steroid late non-responsive nephrotic syndrome compli-
cated by severe permanent visual loss associated with
intracranial hypertension. Patients with renal disease have
many risk factors associated with intracranial hyperten-
sion, including anaemia, fluid abnormalities, and disturbed
endocrine function [9]. Children with nephrotic syndrome
are at a particular risk of thrombosis during episodes ofclinical relapse [10] and the link between cerebral venous
thrombosis and increased intracranial pressure is well
established [11]. Furthermore, patients with renal condi-
tions are also exposed to therapies reported to have been
associated with intracranial hypertension such as cyclo-
sporine [8], or steroid therapy withdrawal [5]. Hence, the
onset of intracranial hypertension in our child may have
been due to these known associations, primarily steroid
withdrawal and cyclosporine therapy. It remains unclear
whether children with renal conditions and raised intra-
cranial pressure form a secondary group or intracranial
hypertension, or are a subgroup of the idiopathic intracra-
nial hypertension (IIH) [12].
Although the association of intracranial hypertension
and renal disease is established in the literature, the pres-
entation of acute visual loss in this group without concur-
rent symptoms presents a diagnostic challenge, especially
when this affects young children like our patient. Visual
failure without headache in IIH has been reported previ-
ously and such children often have a poorer visual out-
come [6]. As visual loss is the only serious complication of
intracranial hypertension, treatment should be tailored to
its presence, which can occur early or late in the clinical
course. Once pressures have been lowered, symptomatic
management of any persisting headache can be the next
priority [5]. It remains unclear if an earlier identification
of raised intracranial pressure in our patient would have
resulted in a better ophthalmic outcome, or if her earlier
headache syndrome was identified as a raised pressure
event. Visual loss without raised intracranial pressure in
nephrotic syndrome has also been reported, manifesting
as a retinopathy [13], or a toxic optic neuronopathy often
attributed to immunomodulation therapy such as tacroli-
mus [14]. In our patient the fundal changes and ophthal-
mic assessments primarily support sequelae of a raised
pressure syndrome.
Despite recognising the association between renal dis-
ease and IIH, the presentation of acute permanent visual
loss can occur in otherwise asymptomatic IIH. Therefore
patient strategies that can potentially reduce the morbid-
ity, as seen in our patient, remain difficult to implement.
Invasive surveillance of CSF pressure is impractical. How-
ever, non-invasive tools are being developed to measure
CSF pressure [15] and for monitoring disc edema [16].
The targeted application of these novel techniques, with
rigorous surveillance of vision (in a selected group of
children with multiple risk factors for raised intracranial
pressure), offers the only realistic measure to prevent
these otherwise devastating sequelae.
Intracranial hypertension needs to be considered and
suspected early to allow prompt initiation of treatment.
Non-invasive monitoring techniques and targeted surveil-
lance in high risk patient groups may provide a way to
identify cases before visual loss is permanent.
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